| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/15/2001 | DE19905913C1 Stabilizing double-stranded nucleic acid, useful e.g. in restoring double strands after sterilization, by incubation with histone-like protein from Thermotoga maritima |
| 02/15/2001 | DE10019864A1 Nucleic acid sequences from alkane metabolizing Candida yeast, encoding cytochrome b5 and used for the oxidation of long chain alkyl compounds and for the production of long chain dicarbonic acids |
| 02/15/2001 | CA2383230A1 Tumor-associated antigen (r11) |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381699A1 Novel methods of diagnosis of angiogenesis compostions and methods of screening for angiogenesis modulators |
| 02/15/2001 | CA2381396A1 Polynucleotides and polypeptides encoded thereby |
| 02/15/2001 | CA2381325A1 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | CA2381293A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | CA2381290A1 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381267A1 Transgenic plants expressing photorhabdus toxin |
| 02/15/2001 | CA2381173A1 Recombinant stable cell clone, its production and use thereof |
| 02/15/2001 | CA2381005A1 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | CA2380633A1 Peptide antagonists of factor viia |
| 02/15/2001 | CA2380549A1 Secretory molecules |
| 02/15/2001 | CA2380302A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | CA2379608A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | CA2379387A1 Methods and compositions for detecting larval taenia solium |
| 02/15/2001 | CA2379165A1 Chimeric proteins |
| 02/15/2001 | CA2379087A1 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/15/2001 | CA2378620A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids |
| 02/15/2001 | CA2378608A1 Compositions and methods related to claudin-7 |
| 02/15/2001 | CA2378460A1 Peptides that block viral infectivity and methods of use thereof |
| 02/15/2001 | CA2378437A1 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 02/15/2001 | CA2378292A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | CA2376065A1 Crystallization and structure determination of staphylococcus aureus elongation factor p |
| 02/15/2001 | CA2374745A1 Proteases and protease inhibitors |
| 02/15/2001 | CA2373814A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/14/2001 | EP1076097A1 METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE |
| 02/14/2001 | EP1076092A2 Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents |
| 02/14/2001 | EP1076091A1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/14/2001 | EP1076066A1 Peptides for lowering blood glucose levels |
| 02/14/2001 | EP1076065A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide |
| 02/14/2001 | EP1075841A1 Pneumococcal vaccines |
| 02/14/2001 | EP1075673A1 Methods of determining protein activity levels using gene expression profiles |
| 02/14/2001 | EP1075662A2 Methods for diagnosing and evaluating cancer |
| 02/14/2001 | EP1075540A1 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 02/14/2001 | EP1075535A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 02/14/2001 | EP1075531A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
| 02/14/2001 | EP1075530A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
| 02/14/2001 | EP1075529A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 02/14/2001 | EP1075524A2 Attenuated influenza viruses |
| 02/14/2001 | EP1075523A2 Structural proteins of fish pancreatic disease virus and uses thereof |
| 02/14/2001 | EP1075522A2 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 02/14/2001 | EP1075521A2 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/14/2001 | EP1075519A2 Inhibitors of nf-kb activation |
| 02/14/2001 | EP1075518A2 Human transcriptional regulator molecules |
| 02/14/2001 | EP1075517A1 Chimeric receptors |
| 02/14/2001 | EP1075516A2 Human proteins having transmembrane domains and dnas encoding these proteins |
| 02/14/2001 | EP1075514A1 Modifying the expression of the fsh beta gene by homologous recombination |
| 02/14/2001 | EP1075495A1 Gprw receptor |
| 02/14/2001 | EP1075494A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075492A1 Melanocortin 1 receptor selective compounds |
| 02/14/2001 | EP1075491A2 Pth2 receptor selective compounds |
| 02/14/2001 | EP1075490A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 02/14/2001 | EP1075487A1 Secreted proteins and polynucleotides encoding them |
| 02/14/2001 | EP1075486A1 Method of treating bladder and lower urinary tract syndromes |
| 02/14/2001 | EP1075280A2 Hemoglobine-haptoglobin complexes for targeted durg delivery |
| 02/14/2001 | EP1075275A1 Use of interleukin-18 as vaccine adjuvant |
| 02/14/2001 | EP1075273A2 Inhibiton of helicobacter pylori proliferation |
| 02/14/2001 | EP1075270A1 Short peptides for treatment of neurological degenerative diseases |
| 02/14/2001 | EP0844874A4 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS |
| 02/14/2001 | EP0787301B1 Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen |
| 02/14/2001 | EP0755438B1 Method for controlling metallophosphate precipitation in high cell density fermentations |
| 02/14/2001 | EP0738280B1 Superactive vip antagonists |
| 02/14/2001 | EP0576590B1 Response element compositions and assays employing same |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284131A Human tyroid protein ZSIG45 and data encoding same |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1284086A Conjugates useful in treatment of prostate cancer |
| 02/14/2001 | CN1284085A Frozen foodstuff |
| 02/14/2001 | CN1284083A Tumor antigen peptide derivatives |
| 02/14/2001 | CN1283997A Keratinocyte growth factor-2 formulations |
| 02/14/2001 | CN1283693A Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB |
| 02/14/2001 | CN1283692A Protein associated with olfaction of human nerve cell and its coding sequence |
| 02/14/2001 | CN1283631A Gene recombination human platelet factor No.4 and its new usage |
| 02/14/2001 | CN1283630A Trichosanthin mutant and its preparing process |
| 02/14/2001 | CN1283629A Antineoplastic gancoderma mycelium-glucoprotein composition and its application and preparing process |
| 02/14/2001 | CN1062015C Gene sequence of coded high-sweetness monellin and method for effeciency expressing said DNA sequence |
| 02/14/2001 | CN1062014C Recombinant gane coding for human alpha interon and expression vector thereof, ETC |
| 02/14/2001 | CN1061992C Colony stimulating factor for recombination of human granulocytes and medicinal compsn thereof |
| 02/14/2001 | CN1061991C Schistosome vaccine peptide NO.3 |
| 02/13/2001 | US6188965 Apparatus and method for automated protein design |
| 02/13/2001 | US6188788 Automatic color saturation control in video decoder using recursive algorithm |
| 02/13/2001 | US6187995 Method for producing disease resistant plant with thionin gene from Avena sativa |
| 02/13/2001 | US6187993 Transgenic animals as model of psoriasis |
| 02/13/2001 | US6187991 Transgenic animal models for type II diabetes mellitus |
| 02/13/2001 | US6187909 Amino acid sequences of receptor to neurologic regulators; antiinflammatory agents |
| 02/13/2001 | US6187908 Tubby 2 polypeptides |
| 02/13/2001 | US6187907 Conjugate of three crosslinked polypeptide chains containing tripeptide or hexapeptide repeat sequences aligned to form triple helix coil and ligand covalently attatched to template; modeling; drug screening |
| 02/13/2001 | US6187904 Amino acid sequences of microbiocidal proteins; for transgenic plants with increased disease resistance |
| 02/13/2001 | US6187759 Canine parvovirus DNA vaccination |
| 02/13/2001 | US6187757 Regulation of biological events using novel compounds |
| 02/13/2001 | US6187751 Biologically active peptide of ob protein |
| 02/13/2001 | US6187749 Methods for variation of chromatin condensation |
| 02/13/2001 | US6187748 Treatment and prevention of hiv |
| 02/13/2001 | US6187742 Method for healing and repair of connective tissue attachment |
| 02/13/2001 | US6187593 Methods for treating a fibrin encapsulated tumor using a fibrin specific monoclonal antibody and compositions used therein |
| 02/13/2001 | US6187579 Customized proteases |